Skip to main content
SpringerLink
Log in

Are Lists of Potentially Inappropriate Medications Associated with Hospital Readmissions? A Systematic Review

  • Systematic Review
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background

Suboptimal prescribing, including the prescription of potentially inappropriate medications (PIM), is frequent in patients aged 65 years and older. PIMs are associated with adverse drug events, which may lead to hospital admissions and readmissions for the most serious cases. Several tools, known as lists of PIMs, can detect suboptimal prescription.

Objective

This systematic review aimed to identify which lists of PIMs are associated with hospital readmission of older patients.

Patients and Methods

MEDLINE, the Cochrane Library, EMBASE, and clinicaltrials.gov were searched for the period from 1 January 1991 up to 12 May 2022 to identify original studies assessing the association between PIMs and hospital readmissions or emergency department (ED) revisits within 30 days of discharge in older patients. This study is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Checklist, and the risk of bias was assessed with the Newcastle–Ottawa Quality Assessment Scale for Cohort Studies (NOS) and the revised Cochrane risk-of-bias tool for randomized trials (RoB 2).

Results

A total of six studies presenting four different lists of PIMs were included. Readmission rates varied from 4.3 to 25.5% and the odds ratio (OR) between PIMs and hospital readmission varied from 0.92 [95% confidence interval (CI) 0.59; 1.42] to 6.48 [95% CI 3.00; 14.00]. Only two studies found a statistically significant association between a list of PIMs and hospital readmission. These two studies used different tools: the Screening Tool of Older Person’s Prescriptions (STOPP) and the Screening Tool to Alert Doctors to Right Treatment (START) and a combination of Beers Criteria® and STOPP and START.

Conclusion

This systematic review shows that the association between list of PIMs and 30-day unplanned readmissions remains unclear and seems dependent on the PIM detection tool. Further studies are needed to clarify this association.

PROSPERO registration number CRD42021252107.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–72.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Thorell K, Midlöv P, Fastbom J, Halling A. Use of potentially inappropriate medication and polypharmacy in older adults: a repeated cross-sectional study. BMC Geriatr [Internet]. 19 févr 2020 [cité 4 févr 2021];20. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032002/. Accessed 4 Feb 2021.

  3. Professeur Sylvie Legrain. Consommation médicamenteuse chez le Sujet Agé : consommation, prescription, iatrogénie et observance. Haute Autorité de Santé; 2005.

  4. Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VMV. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74(6):679–700.

    Article  PubMed  Google Scholar 

  5. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825–32.

    Article  PubMed  CAS  Google Scholar 

  6. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.

    Article  Google Scholar 

  7. By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227–46.

    Article  Google Scholar 

  8. Panel B the 2019 AGSBCUE. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674–94.

    Article  Google Scholar 

  9. Laroche ML, Bouthier F, Merle L, Charmes JP. Médicaments potentiellement inappropriés aux personnes âgées: intérêt d’une liste adaptée à la pratique médicale française. Rev Médecine Interne. 2009;30(7):592–601.

    Article  Google Scholar 

  10. Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arzteblatt Int. 2010;107(31–32):543–51.

    Google Scholar 

  11. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.

    Article  PubMed  CAS  Google Scholar 

  12. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing mars. 2015;44(2):213–8.

    Article  Google Scholar 

  13. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.

    Article  PubMed  CAS  Google Scholar 

  14. Farhat A, Al-Hajje A, Lang PO, Csajka C. Impact of pharmaceutical interventions with STOPP/START and PIM-check in older hospitalized patients: a randomized controlled trial. Drugs Aging. 2022;39:899–910.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L. Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging. 2006;23(1):49–59.

    Article  PubMed  Google Scholar 

  16. Passarelli MCG, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22(9):767–77.

    Article  PubMed  Google Scholar 

  17. Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D. Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review. J Alzheimers Dis JAD. 2018;61(4):1639–52.

    Article  PubMed  Google Scholar 

  18. Lanièce I, Couturier P, Dramé M, Gavazzi G, Lehman S, Jolly D, et al. Incidence and main factors associated with early unplanned hospital readmission among French medical inpatients aged 75 and over admitted through emergency units. Age Ageing. 2008;37(4):416–22.

    Article  PubMed  Google Scholar 

  19. Arendts G, Fitzhardinge S, Pronk K, Donaldson M, Hutton M, Nagree Y. The impact of early emergency department allied health intervention on admission rates in older people: a non-randomized clinical study. BMC Geriatr. 2012;12:8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cloonan P, Wood J, Riley JB. Reducing 30-day readmissions: health literacy strategies. J Nurs Adm août. 2013;43(7–8):382–7.

    Article  Google Scholar 

  21. Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011;155(8):520–8.

    Article  PubMed  Google Scholar 

  22. Wells G, Wells G, Shea B, Shea B, O’Connell D, Peterson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In 2014 [cité 24 mars 2023]. Disponible sur: https://www.semanticscholar.org/paper/The-Newcastle-Ottawa-Scale-(NOS)-for-Assessing-the-Wells-Wells/c293fb316b6176154c3fdbb8340a107d9c8c82bf. Accessed 24 Mar 2023.

  23. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

    Article  PubMed  Google Scholar 

  24. GRADE Working Group. GRADE Handbook. 2013.

  25. Komagamine J, Yabuki T, Kobayashi M. Association between potentially inappropriate medications at discharge and unplanned readmissions among hospitalised elderly patients at a single centre in Japan: a prospective observational study. BMJ Open. 2019;9(11): e032574.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chiu P, Lee A, See T, Chan F. Outcomes of a pharmacist-led medication review programme for hospitalised elderly patients. Hong Kong Med J Xianggang Yi Xue Za Zhi. 2018;24(2):98–106.

    PubMed  CAS  Google Scholar 

  27. Lau MHM, Tenney JW. Evaluation of drug-disease interactions and their association with unplanned hospital readmission utilizing STOPP Version 2 criteria. Geriatrics. 2017;2(4):33.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Basnet S, Zhang M, Lesser M, Wolf-Klein G, Qiu G, Williams M, et al. Thirty-day hospital readmission rate amongst older adults correlates with an increased number of medications, but not with Beers medications. Geriatr Gerontol Int. 2018;18(10):1513–8.

    Article  PubMed  Google Scholar 

  29. Weir DL, Lee TC, McDonald EG, Motulsky A, Abrahamowicz M, Morgan S, et al. Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events. J Am Geriatr Soc juin. 2020;68(6):1184–92.

    Article  Google Scholar 

  30. De Vincentis A, Gallo P, Finamore P, Pedone C, Costanzo L, Pasina L, et al. Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? Drugs Aging. 2020;37(8):585–93.

    Article  PubMed  Google Scholar 

  31. McIlvennan CK, Eapen ZJ, Allen LA. Hospital Readmissions reduction program. Circulation. 2015;131(20):1796–803.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Schwab C, Hindlet P, Sabatier B, Fernandez C, Korb-Savoldelli V. Risk scores identifying elderly inpatients at risk of 30-day unplanned readmission and accident and emergency department visit: a systematic review. BMJ Open. 2019;9(7): e028302.

    Article  PubMed  PubMed Central  Google Scholar 

  33. El Morabet N, Uitvlugt EB, van den Bemt BJF, van den Bemt PMLA, Janssen MJA, Karapinar-Çarkit F. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602–8.

    Article  PubMed  Google Scholar 

  34. Hekkert K, Borghans I, Cihangir S, Westert GP, Kool RB. What is the impact on the readmission ratio of taking into account readmissions to other hospitals? A cross-sectional study. BMJ Open. 2019;9(4): e025740.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Schiavo G, Forgerini M, Lucchetta RC, Silva GO, Mastroianni PDC. Cost of adverse drug events related to potentially inappropriate medication use: a systematic review. J Am Pharm Assoc JAPhA. 2022;62(5):1463-1476.e14.

    Article  CAS  Google Scholar 

  36. Rodrigues DA, Plácido AI, Mateos-Campos R, Figueiras A, Herdeiro MT, Roque F. Effectiveness of interventions to reduce potentially inappropriate medication in older patients: a systematic review. Front Pharmacol. 2022;12:777655.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Xing XX, Zhu C, Liang HY, Wang K, Chu YQ, Zhao LB, et al. Associations between potentially inappropriate medications and adverse health outcomes in the elderly: a systematic review and meta-analysis. Ann Pharmacother. 2019;53(10):1005–19.

    Article  PubMed  Google Scholar 

  38. Unplanned hospital visits [Internet]. [cité 22 sept 2020]. Disponible sur: https://www.medicare.gov/hospitalcompare/Data/Hospital-returns.html. Accessed 22 Sept 2020.

Download references

Acknowledgments

The authors would like to acknowledge Stella Ghouti for the correction of the manuscript.

Author information

Authors and Affiliations

  1. Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpital Saint-Antoine, 75012, Pharmacie, Paris, France

    Camille Schwab, Christine Fernandez & Patrick Hindlet

  2. Université Paris Saclay, Faculté de Pharmacie, Département de Pharmacie clinique, Orsay, France

    Camille Schwab, Alice Clementz, Christine Fernandez & Patrick Hindlet

  3. Assistance Publique-Hôpitaux de Paris, Hôpital Sainte-Périne, Pharmacie, Paris, France

    Alice Clementz

  4. Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Département de Santé Publique, Paris, France

    Agnès Dechartres

Authors
  1. Camille Schwab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alice Clementz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agnès Dechartres
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christine Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patrick Hindlet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Camille Schwab.

Ethics declarations

Funding

Not applicable.

Conflicts of interest:

None to declare.

Availability of Data and Material

Not applicable.

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Code Availability

Not applicable.

Author Contributions

Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data: Camille Schwab, Alice Clementz, Patrick Hindlet, and Agnès Dechartres. Drafting the article or revising it critically for important intellectual content: Camille Schwab, Alice Clementz, Patrick Hindlet, and Christine Fernandez. Final approval of the version to be published: Agnès Dechartres, Christine Fernandez, and Patrick Hindlet. Sponsor’s role: none. All authors have read and approved the final version of the manuscript, and agree to be accountable for the work.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 275 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schwab, C., Clementz, A., Dechartres, A. et al. Are Lists of Potentially Inappropriate Medications Associated with Hospital Readmissions? A Systematic Review. Drugs Aging 41, 209–218 (2024). https://doi.org/10.1007/s40266-024-01099-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-024-01099-9

Search

Navigation